Postprandial VLDL-triacylglycerol secretion is not suppressed in obese type 2 diabetic men

Diabetologia

Volumn 55, Issue 10, 2012, Pages 2733-2740

  Sondergaard E ^a   Sorensen L P ^a   Rahbek, I ^a   Gormsen, L C ^a   Christiansen, J S ^a   Nielsen, S ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Postprandial; Tracer studies; Triacylglycerol; VLDL

Indexed keywords

CARBON 14; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA; TRIACYLGLYCEROL; TRIOLEIN; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC OBESITY; DIABETIC PATIENT; DISEASE ASSOCIATION; ENERGY EXPENDITURE; EX VIVO STUDY; HUMAN; HYPERLIPIDEMIA; KINETICS; LEAN BODY WEIGHT; LIPOGENESIS; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN SECRETION; LOW FAT DIET; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PRIORITY JOURNAL; STEADY STATE; TRIACYLGLYCEROL BLOOD LEVEL; VERY LOW DENSITY LIPOPROTEIN BLOOD LEVEL;

EID: 84866138040     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2624-z     Document Type: Article

References (40)

1. Hokanson JE, Austin MA (1996) Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 3:213-219 (Pubitemid 26266496)
2. Austin MA, Hokanson JE, Edwards KL (1998) Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 81:7B-12B (Pubitemid 28113939)
3. Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration (2010) Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet 375:1634-1639
4. Adler AI, Stevens RJ, Neil A, Stratton IM, Boulton AJ, Holman RR (2002) UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care 25:894-899 (Pubitemid 41094289)
5. Koskinen P, Manttari M, Manninen V, Huttunen JK, Heinonen OP, Frick MH (1992) Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study. Diabetes Care 15:820-825
6. Lewis GF, Steiner G (1996) Acute effects of insulin in the control of VLDL production in humans. Implications for the insulin-resistant state. Diabetes Care 19:390-393 (Pubitemid 26115468)
7. Sorensen LP, Andersen IR, Sondergaard E et al (2010) Basal and insulin mediated VLDL-triglyceride kinetics in type 2 diabetic men. Diabetes 60:88-96
8. Gormsen LC, Nellemann B, Sorensen LP, Jensen MD, Christiansen JS, Nielsen S (2009) Impact of body composition on very-low-density lipoprotein- triglycerides kinetics. Am J Physiol Endocrinol Metab 296:E165-E173
9. Duvillard L, Florentin E, Fdr P et al (2011) Endogenous chronic hyperinsulinemia does not increase the production rate of VLDL apolipoprotein B: proof from a kinetic study in patients with insulinoma. J Clin Endocrinol Metabol 96:2163-2170
10. Shumak SL, Zinman B, Zuniga-Guarjardo S, Poapst M, Steiner G (1988) Triglyceride-rich lipoprotein metabolism during acute hyperinsulinemia in hypertriglyceridemic humans. Metabolism 37:461-466
11. Malmstrom R, Packard CJ, Caslake M et al (1997) Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia 40:454-462 (Pubitemid 27132616)
12. Adiels M, Westerbacka J, Soro-Paavonen A et al (2007) Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance. Diabetologia 50:2356-2365 (Pubitemid 47512396)
13. Mittendorfer B, Patterson BW, Klein S, Sidossis LS (2003) VLDL-triglyceride kinetics during hyperglycemia-hyperinsulinemia: effects of sex and obesity. Am J Physiol Endocrinol Metab 284:E708-E715
14. Lewis GF, Uffelman KD, Szeto LW, Weller B, Steiner G (1995) Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest 95:158-166
15. Gormsen LC, Jensen MD, Schmitz O, Moller N, Christiansen JS, Nielsen S (2006) Energy expenditure, insulin, and VLDL-triglyceride production in humans. J Lipid Res 47:2325-2332 (Pubitemid 44936143)
16. Gormsen LC, Jensen MD, Nielsen S (2006) Measuring VLDL-triglyceride turnover in humans using ex vivo-prepared VLDL tracer. J Lipid Res 47:99-106 (Pubitemid 43107453)
17. Steele R (1959) Influences of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci 82:420-430
18. De Bodo RC, Altszuler N, Dunn A, Steele R, Armstrong DT, Bishop JS (1959) Effects of exogenous and endogenous insulin on glucose utilization and production. Ann NY Acad Sci 82:431-451
19. Jensen MD, Heiling V, Miles JM (1990) Measurement of non-steady-state free fatty acid turnover. Am J Physiol Endocrinol Metab 258:E103-E108
20. Jensen MD, Kanaley JA, Reed JE, Sheedy PF (1995) Measurement of abdominal and visceral fat with computed tomography and dual-energy x-ray absorptiometry. Am J Clin Nutr 61:274-278
21. Guo Z, Nielsen S, Burguera B, Jensen MD (1997) Free fatty acid turnover measured using ultralow doses of [U-13C]palmitate. J Lipid Res 38:1888-1895 (Pubitemid 27411280)
22. Sorensen LP, Gormsen LC, Nielsen S (2009) VLDL-TG kinetics: a dual isotope study for quantifying VLDL-TG pool size, production rates, and fractional oxidation in humans. Am J Physiol Endocrinol Metab 297:E1324-E1330
23. Wolfe RR, Peters EJ, Klein S, Holland OB, Rosenblatt J, Gary H (1987) Effect of short-term fasting on lipolytic responsiveness in normal and obese human subjects. Am J Physiol Endocrinol Metab 252:E189-E196
24. Annuzzi G, de Natale C, Iovine C et al (2004) Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol 24:2397-2402 (Pubitemid 39658048)
25. Hodson L, Bickerton AST, McQuaid SE et al (2007) The contribution of splanchnic fat to VLDL triglyceride is greater in insulin-resistant than insulin-sensitive men and Women. Diabetes 56:2433-2441 (Pubitemid 47523250)
26. Schneeman BO, Kotite L, Todd KM, Havel RJ (1993) Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoproteins B-48 and B-100 to a fat-containing meal in normolipidemic humans. Proc Natl Acad Sci USA 90:2069-2073 (Pubitemid 23069999)
27. Cohn JS, Johnson EJ, Millar JS et al (1993) Contribution of apoB-48 and apoB-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters. J Lipid Res 34:2033-2040 (Pubitemid 24000952)
28. Tushuizen ME, Pouwels PJ, Bontemps S et al (2010) Postprandial lipid and apolipoprotein responses following three consecutive meals associate with liver fat content in type 2 diabetes and the metabolic syndrome. Atherosclerosis 211:308-314
29. Matikainen N, Manttari S, Westerbacka J et al (2007) Postprandial lipemia associates with liver fat content. J Clin Endocrinol Metab 92:3052-3059 (Pubitemid 47236370)
30. Lewis GF, Zinman B, Uffelman KD, Szeto L, Weller B, Steiner G (1994) VLDL production is decreased to a similar extent by acute portal vs peripheral venous insulin. Am J Physiol Endocrinol Metab 267:E566-E572
31. Lewis GF, Uffelman KD, Szeto LW, Steiner G (1993) Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals. Diabetes 42:833-842 (Pubitemid 23151575)
32. Malmstrom R, Packard CJ, Caslake M et al (1998) Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects. Diabetes 47:779-787 (Pubitemid 28201808)
33. Malmstrom R, Packard CJ, Watson TD et al (1997) Metabolic basis of hypotriglyceridemic effects of insulin in normal men. Arterioscler Thromb Vasc Biol 17:1454-1464 (Pubitemid 27329873)
34. Lewis GF (1997) Fatty acid regulation of very low density lipoprotein production. Curr Opin Lipidol 8(3):146-153 (Pubitemid 27290460)
35. Robertson MD, Parkes M, Warren BF et al (2003) Mobilisation of enterocyte fat stores by oral glucose in humans. Gut 52:834-839 (Pubitemid 36613490)
36. Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD (2004) Splanchnic lipolysis in human obesity. J Clin Invest 113:1582-1588 (Pubitemid 39071681)
37. Cummings MH, Watts GF, Umpleby AM et al (1995) Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM. Diabetes 44:1059-1065
38. Nordestgaard BG, Langsted A, Freiberg JJ (2009) Nonfasting hyperlipidemia and cardiovascular disease. Curr Drug Targets 10:328-335
39. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A (2007) Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298:299-308 (Pubitemid 47080484)
40. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM (2007) Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 298:309-316 (Pubitemid 47080485)